| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Bryan Baldasare | Exec VP & CFO | $1.24M | Dec 15, 2021 | ||
| David Phillips | Director | $286K | Jan 12, 2022 | ||
| Catherine Sazdanoff | Director | Jan 31, 2023 | |||
| Lourdes Weltzien | Executive VP, Life Science | Jan 31, 2023 | |||
| Julie Diana Smith | Sr VP, Controller, PAO | Jan 31, 2023 | |||
| John McCune Rice Jr. | Director | Jan 31, 2023 | |||
| Felicia Williams | Director | Jan 31, 2023 | |||
| Anthony P. Bihl III | Director | Jan 31, 2023 | |||
| John P. Kenny | Chief Executive Officer, Director, 10%+ Owner | Jan 31, 2023 | |||
| Tony Serafini-Lamanna | Executive VP-Diagnostics | Jan 31, 2023 | |||
| Dwight Ellingwood | Director | Jan 31, 2023 | |||
| Andrew S. Kitzmiller | Executive Vice President & CFO | Jan 31, 2023 | |||
| John McIlwraith | Director | Jan 31, 2023 | |||
| James Anderson | Director | Jan 31, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|